Celularity Inc. Class A Common Stock
Veridion Score
BETALOW CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is CELU moving today?
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
CELU overview
Related filings and maps
Congress activity in CELU
No receipt-qualified Congressional disclosure is present for CELU in the cached public ledger.
CELU contract awards, year to date.
Public federal awards linked to this ticker.
CELU lobbying filings, year to date.
Registered lobbying filings matched to Celularity Inc. Class A Common Stock.